Unlike headaches, migraines can last for several days and can have warning signs to look out for before they happen.

Most pediatric patients with migraine have normal imaging, supporting that routine scans rarely aid diagnosis or alter migraine management.

Atogepant 60 mg vs rimegepant and galcanezumab for episodic migraine prevention has superior efficacy, with comparable safety across treatments.

In a post hoc REVIEW study analysis, researchers compared self-reported outcomes by level of improvement in good days/month with eptinezumab.

An observational study examined ESKD risk among patients with migraine taking vs not taking topiramate. The migraine drug topiramate may provide kidney health benefits, according to research.

MONDAY, June 30, 2025 (HealthDay News) -- For adults with obesity and migraine, liraglutide reduces migraine burden, with reductions in mean monthly headache days and Migraine Disability Assessment ...

Aspartame has been linked to pediatric and adolescent migraines. Upon ingestion, aspartame is broken, converted, and oxidized into formaldehyde in various tissues. The authors present a case of ...

People with chronic migraine felt their logistic, emotional, and financial support of their families all suffered because of their migraine disease.

mMR is associated with better treatment response than gepants in patients with migraine who previously had an inadequate response to gepants.

Lundbeck advances leadership in migraine with new data at the American Headache Society 67th Annual Scientific MeetingIn a post-hoc analysis of the DELIVER trial, interictal periods were longer ...

Neurologists share how AI is currently being studied to help diagnose and better treat migraine in the future.